Biogen (BIIB) Work In Process (2010 - 2018)
Biogen (BIIB) posted quarterly Work In Process of $606.7 million for Q4 2018, little changed year-over-year from $605.7 million in Q4 2017, and little changed quarter-over-quarter from $605.7 million in Q4 2017.
Biogen (BIIB) Work In Process (2010 - 2018) Analysis & Trends
Biogen's Work In Process history runs 9 years deep, the most recent figure standing at $606.7 million for Q4 2018.
- In Q4 2018, Work In Process changed 0.17% year-over-year to $606.7 million; the TTM figure through Dec 2018 stood at $606.7 million (changed 0.17% YoY), while the FY2018 annual figure was $606.7 million, changed 0.17% from the prior year.
- Work In Process for Q4 2018 stood at $606.7 million, roughly flat from $605.7 million in the prior quarter.
- The five-year high for Work In Process was $698.7 million in Q4 2016, with the low at $511.5 million in Q4 2014.
- The 5-year median for Work In Process is $605.7 million (2017), against an average of $600.0 million.
- The sharpest annual moves came in 2016 and 2017: Work In Process rose 20.97% in 2016, then dropped 13.31% in 2017.
- Biogen's Work In Process stood at $511.5 million in 2014, then grew by 12.92% to $577.6 million in 2015, then grew by 20.97% to $698.7 million in 2016, then decreased by 13.31% to $605.7 million in 2017, then climbed by 0.17% to $606.7 million in 2018.
- Business Quant data shows BIIB's Work In Process at $606.7 million in Q4 2018, $605.7 million in Q4 2017, and $698.7 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 606.70 Mn |
| Dec 31, 2017 | 605.70 Mn |
| Dec 31, 2016 | 698.70 Mn |
| Dec 31, 2015 | 577.60 Mn |
| Dec 31, 2014 | 511.50 Mn |
| Dec 31, 2013 | 435.40 Mn |
| Mar 31, 2013 | 276.10 Mn |
| Dec 31, 2012 | 244.90 Mn |
| Jun 30, 2012 | 166.80 Mn |
| Mar 31, 2012 | 163.50 Mn |
| Dec 31, 2011 | 169.40 Mn |
| Dec 31, 2010 | 142.20 Mn |